BGNE (BeOne Medicines) Margin bathi reged

Lambang korporat lan logo BeOne Medicines (BGNE)

Geopolitical risks and R&D costs are creating financial pressure, yet the expansion strategy and the displacement of legacy drugs in the US and Europe offset these threats for BeiGene, Ltd. (BGNE). The gross income metric in the GURU.Markets system confirms the effectiveness of this model, where the current figure stands at 87.40. Modern plants in China and a biopharmaceutical complex in New Jersey guarantee the stability of the business.

BGNE - Margin reged BeOne Medicines ing rentang 04.07.2022 - 20.11.2026

Rincian analitis lan laporan data perusahaan BeiGene, Ltd. (BGNE)

- rega pasar lan target rega analis:
Ringkesan analisis perusahaan:BeiGene - BGNE
Produk sing diprodhuksi BeiGene Ltd

Fundamental asset selection requires analyzing cost management efficiency through key reporting metrics. Gross margin measures the portion of revenue remaining after paying direct production costs, reflecting the business's internal resilience to raw material inflation. For BeiGene, Ltd. (BGNE), this metric is critical, as colossal expenditures on global oncology research and geopolitical pressure on R&D chains directly determine the trend on the gross margin chart.

Pesaing langsung

Margin bathi reged BeiGene Ltd. (ONC)|Tingkat bathi miturut bathi reged HALO|Rentabilitas reged RVMD|Tingkat bathi miturut bathi reged AAPG (Ascentage)|Tingkat bathi miturut bathi reged cgoncology.com CGON|UroGen Pharma - Tingkat bathi miturut bathi reged|Tingkat bathi reged BCAX|PSNL - Rentabilitas reged|Rentabilitas dodolan miturut bathi reged Erasca Oncology ERAS|delcath.com (DCTH) - Rentabilitas reged|Y-mAbs Therapeutics - Tingkat bathi reged|AURA (Aura Biosciences Inc) - Margin reged|Margin bathi reged candeltx.com CADL|Margin reged ARAY|SLS (SELLAS Life Sciences Group, Inc.) - Tingkat bathi reged|Rentabilitas reged Actuate Therapeutics, Inc. ACTU|citiusonc.com - Rentabilitas reged|TuHURA Biosciences Inc. - Margin reged|TARA - Margin reged|FATE (Fate Therapeutics) - Tingkat bathi miturut bathi reged|Tingkat bathi miturut bathi reged Aadi Bioscience, Inc.|Tingkat bathi miturut bathi reged TCRX|Rentabilitas reged CSBR|Margin reged XBIT|Rentabilitas dodolan miturut bathi reged CEL-SCI Corp.|Rentabilitas reged ostherapies.com OSTX|RADX: Rentabilitas dodolan reged|ARTV: Tingkat bathi miturut bathi reged|ANL (Adlai Nortye) - Rentabilitas dodolan reged|Veru (VERU) - Rentabilitas reged|Tingkat bathi miturut bathi reged Tempest Therapeutics Inc|Rentabilitas reged Xilio Therapeutics|Rentabilitas dodolan reged RENB (Renovaro Inc.)|Rentabilitas reged Mural Oncology PLC (MURA)|Margin reged Kairos Pharma (KAPA)|Rentabilitas reged onkuretherapeutics.com OKUR|GDTC: Rentabilitas dodolan reged|CRIS: Tingkat bathi miturut bathi reged|apollomicsinc.com (APLM) - Tingkat bathi miturut bathi reged|THAR: Margin reged|Tingkat bathi miturut bathi reged Advanced Biomed Inc.|Tingkat bathi miturut bathi reged GNPX|Rentabilitas dodolan reged CLDI (Calidi Biotherapeutics)|Margin reged SBFM|Xenetic Biosciences, Inc. - Rentabilitas dodolan reged|Rentabilitas reged Salarius Pharmaceuticals SLRX|Margin reged purple-biotech.com PPBT|AONC - Rentabilitas reged|Checkpoint Therapeutics, Inc. (CKPT) - Tingkat bathi miturut bathi reged|ELEV (Elevation Oncology, Inc.) - Tingkat bathi miturut bathi reged|iCAD Inc. - Tingkat bathi reged|Tingkat bathi miturut bathi reged IKNA|Margin reged notablelabs.com|Tingkat bathi miturut bathi reged VIRX (Viracta Therapeutics Inc.)|MOR - Margin bathi reged|Rentabilitas reged NAYA Biosciences NAYA|AAPGV - Tingkat bathi miturut bathi reged